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Abstract. This work provides new insight into the age-related basis of Alzheimer’s disease (AD), the composition of
intraneuronal amyloid (iA), and the mechanism of an age-related increase in iA in adult AD-model mouse neurons. A
new end-specific antibody for A45 and another for aggregated forms of A provide new insight into the composition of iA
and the mechanism of accumulation in old adult neurons from the 3xTg-AD model mouse. iA levels containing aggregates
of A45 increased 30-50-fold in neurons from young to old age and were further stimulated upon glutamate treatment.
iA was 8 times more abundant in 3xTg-AD than non-transgenic neurons with imaged particle sizes following the same
log-log distribution, suggesting a similar snow-ball mechanism of intracellular biogenesis. Pathologically misfolded and
mislocalized Alz50 tau colocalized with iA and rapidly increased following a brief metabolic stress with glutamate. APP-
CTF, A45, and aggregated A colocalized most strongly with mitochondria and endosomes and less with lysosomes and
autophagosomes. Differences in iA by sex were minor. These results suggest that incomplete carboxyl-terminal trimming of
long As by gamma-secretase produced large intracellular deposits which limited completion of autophagy in aged neurons.
Understanding the mechanism of age-related changes in iA processing may lead to application of countermeasures to
prolong dementia-free health span.
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INTRODUCTION
Age has long been known to be the most significant
risk factor for AD, but how age is related to dis-
ease and whether the relationship is mediated through
amyloid- (A) and tau pathology remains unknown.
The amyloid hypothesis [1–3] has formed the basis
for the development and testing of many therapeutics;
however, none of these have been successful and the
gamma-secretase inhibitor, Semagacestat, actually
led to a significant worsening of functional ability in
∗Correspondence to: Greg Brewer, Department of Biomedical
Engineering, University of California Irvine, Irvine, CA 92697,
USA. E-mail: GJBrewer@uci.edu.
human clinical trials [4]. Although gamma-secretase
inhibitors were screened on the basis of their inhi-
bition of the secretion of A, a detailed analysis of
the mechanism indicated that Semagacestat slows the
tripeptide carboxypeptidase terminal triming of the
primary products of gamma-secretase endoproteoly-
sis leading to the accumulation of “long As” ending
at residues 45, 46, 48, and 49 of the A sequence
(Fig. 1), similar to many of the FAD mutations in
presenilin, which interfere with the processivity of
the tripeptidase trimming [5–7]. These results suggest
that the reason that Semagacestat and Avagacestat
[8] caused cognitive worsening is the same reason
that FAD mutations in presenilins cause early onset
ISSN 1387-2877/20/$35.00 © 2020 – IOS Press and the authors. All rights reserved
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Fig. 1. Routes for intracellular A for aggregation of insoluble
“long A” peptides. Above, red arrows mark initial endoprotease
cleavage of APP. Smaller black arrows show trimming to A45
and A42. Normally, secreted soluble “short A” peptides of 40 or
less residues are rapidly degraded. Site of mOC78 antibody recog-
nition sequence for aggregated A shown at residues 9-13. Below,
stimulation of endocytosis of APP is promoted with 1) BACE
cleavage of APP to CTF1-99 at plasma membrane or 2) in endo-
some. 3) Subsequent processing by gamma-secretase cleavage of
CTF99 into A, 4) long A forms aggregate in the membrane or in
the lumen of late endosomes, 5) further aggregation leads to accu-
mulation inside the endosome or endolysosome. Organelle markers
are shown for co-localization studies. Separately, A forms are
associated with mitochondria and macroautophagy with markers
for these compartments.
AD: they lead to an increase in intraneuronal long
As, implicating them as key players in pathogenesis.
Intraneuronal amyloid is a complex mixture of insol-
uble amyloid- protein precursor (APP) carboxyl
terminal fragments and A species [9–13], reviewed
in [14]. This material is aggregated in the same man-
ner as amyloid aggregates because it reacts with a
variety of aggregation-specific antibodies [15–17].
The accumulation of intraneuronal amyloid appears
to be critical for neuritic plaque formation because
treatment of 5xFAD mice with a CSF1R inhibitor
that ablates microglia blocks intraneuronal amyloid
accumulation and the subsequent deposition of neu-
ritic plaques [18]. Here we report direct evidence
for the acummulation of intraneuronal long As as a
function of age, endocytosis, and excitotoxicity.
We have proposed a modified amyloid hypothesis
that the intraneuronal amyloid contains “long” A
species ending at residues 45 to 49 that arise as a result
of incomplete carboxy terminal trimming activity of
gamma-secretase (Fig. 1) [17]. Although the standard
model of the amyloid cascade hypothesis favored the
view that soluble secreted A is the central player
in AD, the same facts support an alternative model
that postulates a pathogenic role for intracellular
aggregated A (iA), longer fragments of APP con-
taining the A sequence, collectively named “long
As”. We hypothesize that long A isoforms such as
A45 remain and aggregate inside neurons and are not
secreted, in contrast to A42, which is preferentially,
though not exclusively secreted (Fig. 1).
Many assume that a lifelong buildup of extracellu-
lar amyloid or reactive oxygen species (ROS) damage
eventually reaches a clinical threshold for dementia.
However, neither mouse models nor human anti-
amyloid or anti-oxidant therapies have validated this
assumption. We have proposed that metabolic adap-
tation to a sedentary lifestyle impairs mitochondrial
function with less energy for healthy management
of amyloid and tau proteostasis, synaptic function,
inflammation [18], ROS, and other stressors. This
Epigenetic Oxidized Redox Shift (EORS) theory of
aging postulates that an age-related oxidized redox
shift causes a metabolic shift, epigenetic changes and
a futile cycle of declining capacity with age [19, 20].
Here, we hypothesize that these changes increase A
processing and intracellular aggregation. We examine
these changes in iA at the single-cell level.
To elucidate the age-related processing of these
forms, we cultured neurons from adult brains of the
3xTg-AD mouse, compared to non-transgenic neu-
rons in which synthesis and processing of APP is
naturally driven. This transgenic model incorporates
human mutations for accelerated overproduction of
A, yet memory impairment is delayed for many
months. Our methods provide uniform conditions
for comparing epigenetically enforced, age-related
changes, removed from individual variations in hor-
mones, vasculature, and the immune system. This
allowed us to address the largest risk factor for AD,
age. Here we report that iA contains long A45 and
its accumulation in mitochondria, endosomes, and
autophagosomes is dramatically increased with aging
and upon glutamate treatment.
MATERIALS AND METHODS
Mouse models
We used the triple transgenic mouse model of
AD (3xTg-AD) with human transgenes APP (Swe,
KM670/671NL) and Tau (P301L) under the control
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of Thy1.2 promotors in a PS1 (M146V) transgenic
mouse [21]. The mice were housed 1 to 5 per cage
and fed rodent diet 2020X (Envigo Teklad, Placen-
tia, CA) with 24% calories from protein, 16% from
fat, and 60% from carbohydrates). Room tempera-
ture was controlled at 70◦ F, humidity at 16–25%
with a 12-h light dark cycle. Non-transgenic controls
were C57/BL6, bred in house but obtained orig-
inally from Charles River (San Diego, CA). The
5XFAD (B6SJL-Tg(APPSwFlLon,PSEN1*M146
L*L286V)6799Vas/Mmjax) mice from The Jack-
son Laboratory [22] were genotyped by qPCR
(automated genotyping using human APP and
PS1 primers, TransnetYX, Cordova, TN) to ensure
expression of comparable levels of the human APP
and PS1 genes.
Primary neuron culture
1 mL isoflurane, USP (Piramal Healthcare, Beth-
lehem, PA 66794-013-25) was used to anesthetize
the mice. Adult hippocampal and overlaying cortical
neurons were isolated separately from female or male
young (2, 4, and 6 months), middle-age (9, 10, and
11 months) and old (21 months) nTg and 3xTg-AD
mice [23]. The combined hippocampus and overly-
ing frontal cortex of each hemisphere were sliced
at 0.5 mm and combined in Hibernate AB (Brain-
Bits LLC, Springfield, IL, #HAB 500) and placed
into 30◦C bath for 8 min. The tissue was digested
with 2 mg/ml papain (Worthington, Lakewood, NJ,
LS003119) in Hibernate A minus Calcium (Brain-
Bits HACA) and 0.5 mM Glutamax (Thermo Fisher,
Waltham, MA, 35050-061) for 30 min in 30◦C dry
bath while shaking at 170 rpm. The slices were trit-
urated, and each hippocampus and hemicortex was
transferred to a separate 15 mL tube of Optiprep
(Cosmo Bio, Carlsbad, CA, AXS-1114542) of 4 lay-
ered densities. The two gradients were centrifuged
at 800 g for 15 min. The neuron enriched fractions
were collected and transferred to 5 mL of Hibernate
AB. The cell suspension was centrifuged twice for
1 min at 200 g and the supernatant was discarded.
The cells were plated onto Poly-D-lysine (Sigma-
Aldrich, St Louis, MO, P6407-5MG) coated 12 mm
coverslips (Carolina Biologicals, Burlington, NC,
41001112) at 50,000 cell/cm2 in Neurobasal plus
with B27 plus (Thermo Fisher A3653401) supple-
mented with 5 ng/mL each mouse FGF2 (Thermo
Fisher, PMG0035 or Pepro-Tech 450-33) and PDGF-
BB (PMG0045 or Pepro-Tech 315-18) for trophic
support. The medium was adjusted from 235 to 270
mOsm with 5 M NaCl. One-half medium changes
were made on days 4 and 7 with 10 ng/mL growth
factors, assuming consumption of the prior growth
factors. The cells were cultured for 10–15 days at
37◦C in 5% CO2 and 9% O2 at saturated humidity
(Thermo-Forma, Marietta, OH, Model 3130). Qual-
ity control was maintained above 80% viability at all
time points in about 90% of cultures by a live-dead
assay.
Live-dead assay
The live neurons on glass coverslips were
stained with fluorescein diacetate (15g/mL; Sigma-
Aldrich, F7378) and propidium iodide (4.6g/mL;
Sigma-Aldrich, P4170) [24]. After 2 min of incuba-
tion, the cells were rinsed once with Hibernate A Low
Fluorescence (BrainBits LLC, HALF), and the wash
was saved so the suspended dead cells could also be
examined. Images were taken with the fluorescent
microscope Olympus IX83 at 20X magnification for
green (live) and red (dead) fluorescence. Viability was
calculated as the average percent live divided by the
total adherent cells (live + dead) in 10 adjacent fields,
added to non-adherent dead cells.
Polyclonal serum against Aβ45
A peptide corresponding to residues 36–45 of the
A/APP-CTF99 sequence (VGGVVIATVI) was
synthesized and coupled to keyhole limpet hemo-
cyanin via its amino terminus using disuccinimidyl
suberate (DSS, Thermo Fisher 21555) according to
the manufacturer’s instructions. Two New Zealand
white rabbits were immunized with 1 mg of the result-
ing antigen in incomplete Freund’s adjuvant and
boosted at monthly intervals and bled according to
an IACUC approved protocol under contract with
ProMab Biotechnologies, Richmond, CA. We also
immunized rabbits with 10 residue peptides corre-
sponding to the carboxyl terminus of A ending at
residues 46, 47, 48, and 49, but these immuniza-
tions did not result in a detectable, specific immune
response (data not shown). The specificity of the
resulting antisera from bleed 4 was determined by
spotting 1g of A40, A42, A36-45, A37-46,
A38-47, A39-48, A40-49, and a bridging peptide
corresponding to A36-54. A45 specific antibodies
were affinity purified by passing the serum over a col-
umn of the bridging peptide A36-54, adsorbing the
eluate on a column of A36-45 and eluting the bound
antibody with 0.2 M glycine, pH 2.3. The eluted anti-
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body was rapidly neutralized with 10 mM Tris buffer,
pH 8.0 and stored at 4◦C.
Immunocytochemistry
The cultured neurons attached to glass cover-
slips were fixed with 4% paraformaldehyde (Electron
Microscopy Science, Hatfield, PA, 19200) in Dul-
becco’s phosphate buffered saline minus calcium
(Thermo Fisher, 14190-144) for 10 min. A block-
ing buffer containing 2% Bovine Serum Albumin
(Sigma-Aldrich, SLBT0168), 0.5% Triton X-100
(Sigma-Aldrich, X100-100ML) in DPBS minus Ca
was added to the coverslips for 1 h. Table 1 lists
the primary antibodies used and their dilutions in
antibody dilution buffer (ABD, 1% bovine serum
albumin (BSA), 0.05% Triton X-100 in DPBS-
CA): anti-MAP2 for characterizing neurons, mOC78
[16] for oligomeric amyloid fibrils, anti-Ab45 for
long A protein with residue 45 at the C-terminus,
anti-cathepsin D for lysosomes [25], anti-Rab7a for
endocytic vesicles [26, 27], anti-cytochrome C for
mitochondria [28] and anti-p62 for autophagosomes
[29]. The primary antibodies were allowed to bind
over night at 4◦C. Secondary antibodies were diluted
in antibody dilution buffer (1% BSA, 0.05% Triton X-
100 in PBS) and were allowed to bind for 1 h at room
temperature. As a specificity control, we expressed
a fusion protein consisting of the carboxyl terminus
of GST fused to the amino terminus A45 in E. coli
and purified the fusion protein on glutathione agarose
beads. The conjugate (1:250) was mixed with primary
anti-A45 (1:1000) for specific adsorption immedi-
ately before binding to neurons.
The stained slips were washed 3 times in antibody
dilution buffer with 5 min between each wash. The
nuclei were stained for 2 min with 1 ng/mL bisbenza-
mide (from a 1g/mL stock, Sigma-Aldrich, B1155).
The stained coverslips were mounted on glass slides
using 1 drop of Aqua-Mount (Thermo Fisher, 13800).
The stained coverslips were imaged using an
Olympus IX83 epi-fluorescent microscope with 60X
oil-immersion objective using Olympus dichroic fil-
ters for DAPI (bisbenzamide), GFP (Cathepsin D,
MAP2, Alz50 or Rab7), and RFP (mOC78 or Ab45).
Images were collected by a Retiga Exi camera
(12-bit resolution, CCD; QImaging, Surrey, BC,
Canada) controlled by Metamorph software (Molec-
ular Devices, San Jose, CA). Illumination, exposure
times, camera gain were held constant for each sin-
gle experiment within each antibody, but exposures
were different for detection of each color, avoiding
saturation. ImageJ v1.51n (NIH, Bethesda, MD) soft-
ware was used for analysis of fluorescence images.
Background fluorescence was first removed from all
images with a rolling ball radius of 20 pixels. Min-
imum threshold was set to minimize objects from
samples with the primary antibodies omitted. Inte-
grated density per cell was the area of fluorescent
objects multiplied by their intensity per field divided
Table 1
Antibodies used for immunocytology
Antibody Type Source Dilution
Primary antibodies
Anti-mOC78 Rabbit monoclonal [17, 30] 1:40
Residues 8–11(SGY), 20–24(FEV)
Anti-A45 Rabbit affinity purified
polyclonal this work 1:1000
Anti-APP CTF Rabbit polyclonal [17] 1:1000
Residues 676–695 of APP695
Anti-amyloid 6E10 Mouse monoclonal Covance Signet 1:1000
Residues 5–7 [30]
Alz-50 Mouse monoclonal [31, 32] 1:20
Anti-Rab5a Mouse monoclonal Sigma-Aldrich (R7904) 1:100
Anti-Rab7a Mouse monoclonal Sigma-Aldrich (R8779) 1:500
Anti-Cathepsin D Mouse monoclonal Calbiochem (IM03) 1:100
Anti-MAP2 Mouse monoclonal Sigma-Aldrich (M4403) 1:250
Anti-cytochrome C Mouse monoclonal BD Bioscience (556432) 1:1000
Anti-p62 Mouse monoclonal Novus Biologicals
(NBP2-23490) 1:500
Secondary antibody conjugates
Anti-mouse Goat anti-mouse
Alexafluor488 Thermo Fisher (A11029) 1:2000
Anti-rabbit Donkey anti-rabbit
AlexaFluor555 Thermo Fisher (A31572) 1:500
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by the number of neurons in that field. The number of
fluorescent objects/cell and their size was also ana-
lyzed. Co-localization with automatic thresholding
(Image J, FIJI version) is based on a pixel by pixel
measure of the Pearson correlation of intensities after
automatic subtraction of pixels with zero correlation
[33, 34]. Pixel size was 0.012m2 with a minimum
of 3 pixels (0.036m2) above threshold to count as
an object. Note that endosomes and lysosomes are
0.01–0.16m2 in cross section [25].
Statistics
Results are presented as mean and standard error.
Statistical significance was determined by using
single factor ANOVA with significance considered
at p < 0.05. Follow-up Fisher’s exact t-tests were
adjusted for repeated measures (Pro-Stat, Pearl River,
NY). File names provided with each figure allow
tracing to original data files for authentication.
RESULTS
Characterization of “long” Aβ antibody and
intraneuronal staining
In order to test the hypothesis that long As accu-
mulate intraneuronally (iA), we immunized rabbits
with the 10-residue peptide of the A sequence end-
ing at residue 45. By immunofluorescence of brain
sections with affinity purified IgG from this serum
(Fig. 2A, B), iA45 was seen in most of the hip-
pocampal neurons in a 2-month-old 5xTg-AD mouse
and much less in nTg mice. These neurons also
stained with the commonly used 6E10 for residues
N1-16 which could tag the commonly reported A40,
A42, or CTF. The serum directed against A45
reacted specifically with only the antigenic peptide
ending at residue 45 (Fig. 2C) and not A42 or
any of the longer peptides in dot blots (Fig. 2D).
Specificity was demonstrated by decreased stain-
ing after adsorption of the A45 antiserum with an
A45-GST conjugate (Fig. 2E, F). We will use this
novel end-specific antiserum against longer A45
and a conformation dependent, aggregation specific
monoclonal mOC78 to monitor iA accumulation
[17, 30].
Age increases iAβ accumulation in adult neurons
We compared the effect of age on the intracellular
abundance and distribution of A45 immunoreac-
tivity (iA45) by isolating and culturing neurons
from 3xTg-AD mice of different ages. We wanted to
determine if age from which neurons were isolated
had a differential effect on iA45 levels. Coincident
processing of neurons from 4- and 11-month-old
middle-age male mice indicated a 30-fold increase in
iA45 immunoreactivity compared to 4-month neu-
rons (Fig. 2G-I). This difference was exhibited with
similar neurite outgrowth at these two ages (Supple-
mentary Figure 1), as previously shown [35–37]. We
note that the objects per cell are low numbers as a
result of fixed scaling for comparison of bright objects
in both the 4- and 11-month neurons.
Parallel log-log distribution of mOC78 imaged
particle sizes in 3xTg-AD and non-Tg neurons
mOC78 reacts with aggregates of A, but not with
APP [9, 17, 30]. The epitope for mOC78 maps to
residues 8–11 (SGYE) of A, but immunoreactivity
is strongly dependent on aggregation and common
to amyloid fibrils from unrelated sequences, suggest-
ing a generic amyloid epitope [23]. Although mouse
A contains an F residue at position 10 instead of
a Y, mOC78 binds equally well to peptides con-
taining an F instead of Y (SG(Y/F)E) [Reyes-Ruiz
and Glabe, manuscript in preparation). We wanted to
determine whether there was a principle size class
of iA aggregates driven by their aggregation or
compartmentalization and how the particles related
to organelles involved in intracellular uptake and
turnover of plasma membrane proteins such as APP
and its fragments. Figure 3A shows the abundance
of red punctate mOC78 immunoreactivity in neurons
from a 3xTg-AD mouse compared to considerably
lower intensities from a non-Tg control (Fig. 3B),
while the green Rab-7 co-labeling for late endosomes
[38, 39] were similar. By enhancing gain of the non-
Tg image in Fig. 3C, we can also see red mOC78
immunoreactivity that was present as far lower inten-
sity (concentration). The increased gain in Fig. 3C
of the same non-Tg field in Fig. 3B results in the
visualization of similar size mOC78-immunoreactive
particles to those in the 3xTg-AD neurons and sug-
gests that they were present from endogenous A at a
much lower concentration in the non-Tg neurons and
that the size distribution does not depend on the over-
expression of the transgenes. Surprisingly, Fig. 3D
shows that the distribution of mOC78 imaged particle
sizes was not gaussian but fit well to a log-log distribu-
tion. The slopes from sizes of 0.1 to 2m2 fit within
1% of each other, but particles in 3xTg-AD neurons
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Fig. 2. Prominent long form of intracellular A45 increases with age of neurons. A new C-terminal antiserum identified iA45 (red) compared
to N-terminal 6E10 (green) in CA1 of A) 2-month-old 5xTg-AD and B) 14-month-old non-Tg mouse. C) APP sequence from residues
36–54 of the A sequence with residues 41–45 underlined. D) Specificity of serum A45 for only its own antigenic peptide on dot blot.
E) Competitive antigen adsorption of the A45 antiserum: –1 is no A45 antiserum, just secondary antibody; 0 is A45 antiserum with no
antigen adsorption; 1:250 is dilution of GST-A45 conjugate premixed with A45 antiserum before binding to cells (n = 33–47 cells, file
180608). G) A45 immunoreactivity in 4-month-old male 3xTg-AD neurons compared to H) neurons from an 11-month-old mouse cultured
at the same time and co-processed. I) Average integrated intensity of iA45 immunoreactivity per cell and objects per cell with age. Note
log scale. Control staining for neurons treated without primary antibody was a density of 113 and 0.2 objects per cell for 4-month neurons;
for 11-month neuron density was 442 and 0.1 objects per cell (N = 35–79 cells each; standard error bars are slightly larger than symbols, file
180329).
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Fig. 3. Parallel distributions of intracellular mOC78 amyloid imaged particle sizes in neurons from 3xTg-AD and non-Tg (NTg) mice. A)
Neurons from a male 11-month-old 3xTg-AD mouse stained with mOC78 (red), Rab7 (green), and bisbenzimide (blue). Enlarged field is
55m wide. B) Neurons from a male 11-month-old non-Tg mouse cultured and stained at the same time and imaged at the same settings
as in A. C) Same field as B, but with gain increased to better visualize mOC78 particle sizes. Enlarged field is 46m wide. D) Distribution
of mOC78 particle sizes on log-log scale. Data was log-binned and least squares fit over the range indicated by arrows. 3xTg-AD from 79
cells, 3899 particles, fit to count/cell = 0.430*10∧(–1.073*size), R2 = 0.999; non-Tg from 96 cells, 1593 particles fit to count/cell = –0.050
* 10∧(–1.067*size), R2 = 0.998. File 180511
were 8 times more abundant, due to the overexpres-
sion of APP genes in these mice. This size range
fits with the size of lysosomes and endosomes [25].
The yellow in Fig. 3 indicates overlap of the mOC78
and the Rab-7 stains, suggesting that mOC78 accu-
mulates in late-endosomes. Notice also that the size
range of mOC78 immunoreactive particles for the
3xTg-AD neurons extends to the size of the whole
neuron, nearly 100m2 (Fig. 3D). The marked devi-
ation from linearity at approximately 2m2 suggests
the termination of a normal mechanism of formation
that exceeds the cell’s ability to degrade these iA
objects. Below (Fig. 8), we specifically address quan-
titative analysis of autophagic co-localization with
various A forms.
Alz-50 tau, Aβ45, and mOC78
immunoreactivities are stimulated by glutamate
Memantine is approved by the FDA for treatment
of AD. It acts as an uncompetitive antagonist of gluta-
mate binding to NMDA receptors [40]. In AD, excess
glutamate is postulated to cause intracellular calcium
overload [41], reductions in AMPA receptors GluR1
and GluR2/3 in CA1 with increased density in the
dentate gyrus [42], decrements in glutamate re-uptake
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[43], and metabotropic receptor activation [44]. Here
we compare the effects of short-term (2 h) glutamate
exposure on a pathology-related conformer of tau
aggregation detected with the Alz-50 antibody [31,
32], mOC78, and iA45. Short-term glutamate treat-
ment produced a large increase in red iA45 deposits
in neurons from an old 3xTg-AD brain (Fig. 4A-C).
In the neurons treated with glutamate for only 2 h,
Alz-50 tau immunoreactivity greatly increased and
redistributed into dendrites (Fig. 4A, B, D). Gluta-
mate rapidly increased the density of iA45 per cell
4-fold while the Alz-50 density increased 2-fold. In
another experiment, with neurons from a middle-age
3xTg-AD brain (Fig. 4E, F), we also saw strong colo-
calization of mOC78 with Alz-50. Treatment with
glutamate increased both markers and altered the Alz-
50 distribution into dendrites, where others have seen
neurofibrillary tangles by electron microscopy [45,
46]. Figures 2 and 3 showed data for male neurons.
The experiments in Fig. 4 involved neurons from
female mice. Comparison of male to female expres-
sion of mOC78 indicated only small differences that
scaled with Rab7 immunoreactivity (Fig. 5). Since
mOC78 male measures were increased over females
in proportion to the mass effect of sex on Rab7,
these results suggest that sex is not a major factor
in the iA accumulation of mOC78 immunoreac-
tivity. With the age-dependence of A45 production
(Fig. 2) and its exacerbation by glutamate (Fig. 4), we
inquired how age and glutamate affected the larger
aggregates of mOC78. Figure 6A and B show rela-
tive amounts of mOC78 immunoreactivity increased
exponentially (50-fold) with age with age from 4 to
21 months. In old age, many large mOC78 aggregates
greater than 1m2 were seen (arrows in Fig. 6A).
A brief treatment with glutamate increased mOC78
density per cell in the young and middle-age neurons
but less so in neurons from old mice. The distribu-
tion of object sizes followed a log-log distribution so
that mean size was not a relevant statistic (Fig. 6C).
Instead, for 21-month neurons the calculated slope of
object size was 20% lower and intercept 20% higher
compared to 11-month size distributions. For small
objects, mOC78 size was similar for 11- and 21-
month neurons, suggesting a similar mechanism of
formation. For larger objects above 1m2, objects
from the old mouse were 2-fold more frequent than
those for the 11-month-old mouse (due to a slope 40%
more shallow). With a short glutamate treatment in
21-month neurons, object size grew rapidly with an
increase in intercept of 1.8-fold and a slope 20% more
shallow. These results suggest that age contributes
to an increased rate of formation of iA mOC78
immunoreactivity, exacerbated by glutamate and pos-
Fig. 4. Large increase in A45 and Alz-50 with glutamate with relocalization of Alz-50 tau to dendrites. A) Alz-50 tau in axons and
soma (green) with low A45 puncta (red) B) increases with 2 h treatment with 0.5 mM glutamate and moves to dendrites (arrow), with
colocalization to anti-A45 puncta in 23-month-old male 3xTg-AD neurons. C) 4-fold increase in A45 with glutamate exceeds D) 2-fold
increase in Alz-50. N = 17–35 cells. File 170406. E) 10-month-old female neurons rescaled to show individual mOC78 objects and overlap
with Alz-50. F) Increase in mOC78 with glutamate treatment and large objects resembling neurofibrillary tangles (arrow). 10-month-old
female 3xTg-AD neurons. File 170726.
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Fig. 5. Small effect of mouse gender on mOC78 and Rab7 immunoreactivity. Male to female comparisons of A) mOC78 and B) rab7
immunoreactivity in neurons from 4-month-old mice. i) integrated density; ii) object counts/cell; iii) area per object. We have reported results
from both male and female mice. To determine how dependent the results were on gender, in one experiment we explicitly compared mOC78
and Rab7 immunoreactivity in neurons from a female to a male 4-month-old 3xTg-AD mouse. A shows an insignificant 15% increase in
mOC78 immunoreactive density per cell in the male compared to the female. The object counts per cell were 43% higher in the male with
33% smaller areas, compared to the female. B shows Rab7 immunoreactive density per cell was 22% higher in the male compared to the
female. The object counts per cell were 36% higher in the male with only 6% smaller areas, compared to the female. Colocalization of
mOC78 with Rab7 was 0.83 for both sexes. Since mOC78 male measures were increased over females in proportion to the mass effect of
sex on Rab7, these results suggest that sex is not a major factor in the iA accumulation of mOC78 immunoreactivity. File 171013.
sibly a decreased rate of clearance (see autophagy
studies below).
Aβ45, mOC78, and AβPP-CTF colocalize with
mitochondria, autophagosomes, endosomes, and
lysosomes
Since the forms of iA processed by autophagy
are unclear, we sought to determine the relationship
of iA forms to cytochrome C as a mitochondrial
marker, p62 that attaches to LCB3 and ubiquitin of
autophagosomes, Rab7a as a marker that links late
endosomes to dynein and kinesin molecular motors,
and cathepsin D for lysosomes [25]. To be more quan-
titative than the yellow overlap of merged colors, we
correlated pixel intensities between A forms and
autophagic markers for cell compartments using the
colocalization function in Image J. Correlations of
intensities at each pixel can range from no correla-
tion of 0 to 1 for perfect correlation. The threshold
for each color is determined automatically. An advan-
tage of this approach is that the degree of correlation
is insensitive to the maximum intensity of each color
[33, 34]. This enabled investigation of which forms
of iA collected in specific autophagic organelles,
known to be affected in AD [45, 46].
Each A form (mOC78, A45, and APP-CTF)
most strongly correlated with the late endosome
marker Rab-7 (Fig. 7A, G) (R = 0.82 ± 0.02, n = 7
cultures (one from Fig. 3), independent of age
from 5-11-month-old mice, 2-3 cultures per A
form). As expected mOC78 co-localized strongly
with the commonly used anti-amyloid antibody 6E10
(R = 0.80 ± 0.02, data not shown). Importantly, an
age-matched control in non-Tg neurons from a 5-
month-old mouse showed a similar correlation of
0.89 ± 0.03 for mOC78 colocalization with Rab7,
despite higher Rab-7 and 5-fold lower mOC78 signal
intensity. One of these was from a non-Tg 5-month-
old male with an r = 0.89 ± 0.03 (n = 58 cells) and
another from an 11-month-old male. In contrast,
Fig. 7B shows the correlation of lysosomal cathep-
sin D to decrease from 0.61 ± 0.03 for mOC78 to
0.48 ± 0.05 for A45 and 0.34 ± 0.02 for APP-
CTF. We interpret these results as less APP-CTF
reaching fusion with lysosomes than A45 and more
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Fig. 6. Exponential deposition of intracellular mOC78 A deposits (red) and misfolded tau (Alz-50 tau, green) with age is accelerated
by glutamate. A) Neurons stained and imaged in the same batch, at the same exposure and gain. Neurons from the 21-month-old mouse
showed large extracellular deposits of mOC78i immunoreactive material (arrows). B) Exponential relationship of mOC78 increase with
age. Zero glutamate: y = 98*100.22x; glutamate: y = 511*100.14x. C) Increase in mOC78 object size with age and glutamate. Distributions
were fit by least squares over the range of 0.1 to 5m2: 11-month objects = 0.634*10–1.18∗size, R2 = 0.997, 35 cells, 3306 objects; 21-month
objects = 0.772*10–0.959∗size, R2 = 0.998, 48 cells, 4801 objects; 21-month with 0.5 mM glutamate objects = 1.021*10–1.053∗size, R2 = 0.994,
51 cells, 4807 objects. Inset shows small sizes on a linear scale with large effect of glutamate. Neurons were from female mice of indicated
ages. File 170726. Density changes with age confirmed in male as exponential, file 180329.
mOC78 in lysosomal compartments; however, better
clearance of APP-CTF cannot be ruled out. Over-
all A forms were less detectable in lysosomes than
the earlier stage of late endosomes. In Fig. 7C and
G, the mitochondrial marker cytochrome C corre-
lated with A forms at r = 0.71, almost as strongly
with mOC78 as Rab-7. The average of 4 experiments
ranging in age from 2 to 11 months, including 1 non-
Tg was fairly consistent at 0.73 ± 0.02. An example
of the strong co-localization is shown in Fig. 7D.
Cytochrome C colocalization with A45 produced a
correlation of 0.73 as well (n = 2, a 5-month-old non-
Tg male and an 11-month-old 3xTg-AD male, files
171005 and 180511, respectively). In Fig. 7E, p62 as
a marker of macroautophagy including mitochondrial
autophagy was considerably lower at r = 0.37 ± 0.04
as exemplified in Fig. 7F and averaged in Fig. 7G.
Together these results suggest a strong presence of
iA forms in late endosomes and mitochondria with
lower levels and sequential processing in lysosomes
and autophagosomes from APP-CTF to A45 and
then mOC78. They suggest impairment in iA pro-
cessing in the 3xTg-AD neurons at the level of fusion
of late-endosomes with lysosomes.
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Fig. 7. iA forms colocalize with markers of autophagy, most strongly for mOC78 with late endosome Rab-7. Each flame graph contains
the pixels from 7–20 neurons of one field. Each point is the Pearson correlation of intensities in one pixel with brighter colors indicating
higher prevalence of specific colocalization intensities. Axes show automated cutoffs for pixels with no overlap. Statistics are for 6 fields.
A) Equally high Rab-7 colocalization (y-axis) with i) mOC78, ii) A45, and iii) CTF (each x-axis). Neurons from an 11-month-old male
3xTg-AD mouse, file 180511, composite images shown in Fig 3. B) Slightly lower colocalization of Cat D with i) mOC78 than with Rab-7;
much lower cathepsin D correlations with ii) A45 and iii) APP-CTF. Neurons from a 6-month-old female 3xTg-AD mouse, file 170901.
C) Strong colocalization of cytochrome C with mOC78 as exemplified in D) field 1 from a 5-month-old 3xTg-AD male, file 171005. E) Poor
colocalization of p62 with mOC78 as exemplified from F) field 4 from a 12-month-old 3xTg-AD female, file 170804 of data. G) Highest
Pearson correlations averaged for three iA forms with Rab-7, followed by cytochrome C (similar for all forms, 2-month-old non-Tg and
3xTg-AD female file 171017, 5-month-old non-Tg and 3xTg-AD male file 171005, 11-month-old 3xTg-AD male file 180511. Significantly
lower correlations for cathepsin D and p62 (cat-D: CTF average r = 0.37, n = 2 6-month-old 3xTg-AD female file 171213, 11-month-old
female file 170830. A45 average r = 0.49, n = 3 6-month-old 3xTg-AD female file 170901, 9-month-old 3xTg-AD male file 170428, 10-
month-old 3xTg-AD male file 170428. p62: r = 0.43 10-month-old 3xTg-AD male file 170512, r = 0.37 11-month-old 3xTg-AD female file
170804).
Differential in vitro kinetics of accumulation of
iAβ markers
Neurons isolated from adult brains begin as spher-
ical somata. As they regenerate axons and dendrites
in culture, the total cellular mass increases. We com-
pared this mass effect to production of iA forms
as determined by antibodies against A45, mOC78,
anti-APP-CTF, and the lysosomal marker Cat D.
With days in vitro, mass as integrated density per
cell and objects per cell increased at least four-fold in
both ages in all measures (Fig. 8). The older age levels
of A45 were about double those of the middle-age
neurons at early times (Fig. 8B, F). At later times,
APP-CTF production increased (Fig. 8C, G). Old-
age neuronal mOC78 levels were almost 100-fold
higher in density and 6-fold higher in objects per cell
than middle-age neurons (Fig. 8D, H). These large
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Fig. 8. Greatest age-related increases in mOC78 by in vitro kinetics. Immunoreactive integrated density of (A) lysosomal Cathepsin D
and (B-D) iA forms for neurons from an 11 (orange) and a 21-month-old (blue) female 3xTg-AD mouse. These results are paralleled by
measures of objects counted per cell (E-H) from the same cells. Similar kinetics for anti-cathepsin D immunoreactivity (A, E), and iA
forms (A, E), A45 (B,F), APP-CTF (C, G), and mOC78 (D, H). Note that panel D, Y axis is log scale. File 170712.
effects suggest that age alters the development and
maturation of mOC78 iA aggregate forms in excess
of the increase in neuron mass or CTF.
Modulation of autophagy and glutamate affects
Aβ45 levels
We pharmacologically modulated autophagy to
determine the effects on A45 levels. If A45
was being cleared by autophagy, then inhibition
of autophagy would be expected to cause A45
accumulation and promotion of autophagy would
accelerate A45 clearance. As a negative control,
we used bafilomycin to inhibit the proton-pumping
ATPase that acidifies lysosomes [47] and prevent
fusion of lysosomes with autophagic vesicles [48].
Figure 9A shows the expected decrease in cathep-
sin D immunoreactive density with bafilomycin,
although the size of reactive objects per cell did not
decrease (Fig. 9B). Independently, p62 for assembly
of autophagosomes also responded with a decrease
in density and object size (Fig. 9C, D). As a positive
control to stimulate autophagy, we used the inhibitor
of mTOR, rapamycin [49]. Rapamycin increased
cathepsin D and p62 levels (Fig. 9A, C) as well as
cathepsin object size (Fig. 9B) and objects per cell
from 112 to 184 (not shown). Interestingly, iA45
immunoreactivity increased with either inhibition
or promotion of autophagy (Fig. 9E) and imaged
particle sizes increased with rapamycin (Fig. 9F).
Furthermore, colocalization of iA45 with cathep-
sin D was unchanged by either change in autophagy
(r = 0.58 ± 0.04). In contrast, the lower correlation
of iA45 with p62 (r = 0.43 ± 0.03) was decreased
further by promotion of autophagy with rapamycin
to 0.32 ± 0.03. These results need to be viewed in
two contexts, differences in iA45 localization to
the endosomal versus the macroautophagy branch
of autophagy and which pathway is affected in
the 3xTg-AD neurons. Figure 9A and C show that
bafilomycin inhibition of lysosomal acidification and
degradation activity increased iA and long iA.
Rapamycin which increases autophagy and increases
the uptake of APP and CTF substrates into endo-
somes and autophagosomes, resulted in an increase
in iA and long iA steady state levels by a different
mechanism. Thus, Fig. 9E and F treatment with glu-
tamate further shows that iA45 immunoreactivity is
increased by the Ca and energetic load of glutamate
as well as bafilomycin alone, but the combination
of bafilomycin + glutamate further increased iA45.
This suggests that an energetic load contributes to
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Fig. 9. Autophagy of iA45 compared to a glutamate burden. A) Cathepsin D immunoreactiivty for lysosomes as integrated density per cell
and B) as object size. C, D) Same measures in sister cultures for macroautophagic marker p62. E, F) same measures for iA45. For each
stain paired with A45 stain, sister cultures were treated with the indicated concentrations of glutamate, the autophagic inhibitor bafilomycin
1A or the autophagic stimulator rapamycin. “–1” represents the adjustment of detection threshold to zero for a sister culture in which the
primary antibody was omitted. Each bar is the average from 31–45 neurons from a 3xTg 10-month-old male, file 170512.
iA45 production. The reduction in A levels follow-
ing stimulation by rapamycin + glutamate suggests
both that autophagic clearance was impaired at rest
and more so following a glutamate pulse, but that
inhibition of an intact autophagic machinery needed
rapamycin to reverse it. We interpret these results as
increased iA45 accumulation from backup of inhib-
ited autophagy and increased iA45 buildup from
promotion of autophagy with inability to degrade or
secrete iA45.
DISCUSSION
New antibodies dissect autophagic steps for
accumulation of iAβ
The composition and aggregation state of iA
has been one of the major controversies surround-
ing the significance of iA. Because of limitations
on the specificity of anti-A antibodies, many inves-
tigators have argued that intraneuronal amyloid was
actually “normal” APP or APP-CTF99. In cul-
tured adult neurons from 3xTg-AD mice across the
age-span with novel antibodies against A45 and
aggregated forms (mOC78 [17]), we address impor-
tant mechanistic questions about the pathways of
iA production and removal with implications for
possible pathology and therapeutics. Here, we found
evidence for substantial accumulation of intracellu-
lar A-related forms, including APP-CTF, long A
peptides ending at residue 45 C-terminal peptide and
aggregated A in the form of mOC78 immunore-
active material. Interestingly, all three forms were
present in Rab-7 late endosomes, while accumulation
into cathepsin D positive lysosomes was strongest for
the mOC78 aggregated iA (Fig. 1), which may be
indicative of further autophagic processing of the late
endosomes.
Autophagy
AD-related deficits in lysosomal and autophagic
processing are well established [45, 46], but the con-
tributions of aging to different forms of iA are
not well documented. Here we were able to com-
pare the colocalization of three forms of iA to
four steps in autophagy in two pathways, endo-
cytosis and macroautophagy. APP interacts with
BACE (-secretase) at the plasma membrane [50],
is internalized and concentrated with BACE in endo-
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somes [51–53]. Whether BACE cleavage of APP
to APP-CTF99 occurs first at the plasma mem-
brane or only subsequent to endocytosis is unclear,
especially since most studies of APP processing
are done in non-neuronal cells and have not studied
how an aging environment and signaling affect this
process [53, 54] (Fig. 1). Early endosomal traffick-
ing is controlled by Rab5. Maturation proceeds by
replacement of Rab5 with Rab7 in late endosomes.
The next step is either return to the plasma mem-
brane for receptor recycling and exocytosis [51] or
fusion with lysosomes, termed autophagolysosomes.
Here we see higher levels of A45 and aggregated
A in late endosomes than in cathepsin D positive
autophagolysosomes, suggesting that some CTF99
is processed by gamma-secretase to A in late endo-
somes. Localized activation of BACE in endosomes
and binding of BACE1 to Rab5 and APP is thought
to generate CTF99 and vesicle enlargement [45]. Sep-
arately, mitochondrial macroautophagy enters from
a separate pathway for fusion with lysosomes. Both
a late endosomal compartment and mitochondria
showed strong colocalization with iA forms. A
weaker colocalization signal with p62-directed for-
mation of macro autophagosomes together with the
above-mentioned weaker lysosomal colocalization
may indicate age and AD-related deficits in several
steps of autophagy. Autophagy may be blocked by
the neuron’s inability to degrade or secrete aggre-
gates of A45. Age-related deficits in bioenergetic
capacity [55] may be an upstream cause of endosomal
or lysosomal limitations on ATPase acidification of
these organelles [56]. Our results here by bafilomycin
inhibition of acidification showed decreased cathep-
sin D positive lysosomes, and macroautophagic p62
levels, while A45 levels increased. These results
suggest additional capacity in these neurons to pro-
duce more A45. A further increase by glutamate in
the presence of bafilomycin indicates additional sig-
naling mechanisms for increased A45. Conversely,
rapamycin treatment to stimulate the mTOR path-
way of autophagy promoted cathepsin D and p62
levels, while only modestly increased A45 levels
were seen with glutamate stimulated inhibition of
autophagy. Recently, Fang et al. 57] demonstrated
that stimulation of mitophagy through NAD+ sup-
plementation, urolithin A, and actinonin diminished
iA in human neuroblastoma cells and improved cog-
nition in APP/PS1 mice. These results support age-
and AD-related deficits in the mTOR pathway [50]
and deficits in pAkt modulation of this pathway [58].
Further work is needed to discriminate between the
fusion process, aspects of energized motor proteins
for vesicle trafficking [59], processing of the A-
CTF motif [11, 60], processing of cytoplasmic A
by chaperone mediated autophagy [61] in age-related
effects on iA accumulation. These results confirm
and extend histology and immunoblot results of age-
related changes in late-endosome regulation in the
APP/PS1 mouse brain [39].
Aging
Age contributed the largest effects seen here
on iA, both as A45 and aggregated mOC78
immunoreactivity. A45 and mOC78 were seen to
increase logarithmically with age. The increases
were greater than 10-fold across the age-span of
the transgenic mouse, both in terms of immunore-
active material per neuron and objects per neuron.
The distribution of object sizes was well-fit by a log-
log relationship, with similar slopes for non-Tg and
3xTg-AD neurons, suggesting a similar mechanism
of formation without the transgenes. An excess of
large particles in the 3xTg-AD neurons from mid-
dle to old age, particles approaching a large portion
of a whole cell, suggest a process unable to be
controlled. Our kinetic studies of development in cul-
ture with constant nutrients, first of dendrites, then
axons and synapses, indicate the strongest effects on
mOC78 aggregation of iA. These log-log distribu-
tions are reminiscent of particle nucleation followed
by increasing creation of surface area for additional
aggregation, a snow-ball effect. Intracellular aggrega-
tion of externally added A1-42 was seen to aggregate
up to 0.2m diameter in SH-SY5Y neuroblastoma
cells [62], but the extent could have been influenced
by the size of the label, the undifferentiated state of the
cells and lack of an aging epigenome. The differences
with age suggest that either the rate of formation
of iA increases or their rate of autophagic clear-
ance decreases with age. Glutamate could do either.
Dissection of the mechanism could be informed
by age-related effects of inhibition or promotion of
autophagy. Age-related energetic deficits in neurons
may be partially responsible [55, 63–66], since age-
related deficits in NADH levels can be restored in
neurons with precursors to NAD [45, 67].
Tau and glutamate
We also found phosphorylated tau as Alz-50
immunoreactivity deposited in forms resembling
neurofibrillary tangles in neurons with iA, espe-
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cially in neurons from old animals. Alz-50 is an early
marker seen in neurofibrillary tangles in AD brains
as well as in normal-appearing neurons [31, 32]. It
remains to be determined how similar our structures
are to the paired helical filaments induced by gluta-
mate in cultured human fetal spinal cord neurons [68]
or embryonic rat neurons [69]. A mechanism for the
calcium effects on iA45 and aggregated tau could be
due to the well-known effects of glutamate on Ca++
entry to stimulate calcineurin [70], old-age limits
on calcineurin activity through phosphorylation [71],
effects on APP processing of AD-related inhibition
of calcineurin by DSCR1 [72], or the bioenergetic
load on the Na-K-ATPase and Ca-ATPase pumps.
Alternatively, the oxidative stress of glutamate expo-
sure could induce energy deficits or impair other
essential functions that contribute to iA, as it does
in neuroblastoma cells [73].
Processing and conclusion
We speculate that age-related signaling for inhi-
bition of C-terminal trimming by gamma-secretase
increases A45 levels whose hydrophobic properties
promote aggregation [Brewer et al., in preparation].
Previous studies have reported that long A peptides
A1-47 and A1-52 aggregate much faster than even
A42 [74] and that these long As are retained and
not secreted from cells [75, 76]. Early work pro-
posed dynamic controls of the processing of A to
regulate the routing toward intra- versus extracellu-
lar accumulation of A [77]. The interpretations of
these results have metabolic and possibly mechanistic
implications for impaired cognition. Some gamma-
secretase inhibitors may promote the increase of toxic
iA due to inhibition of the processivity [78]. Even
shorter amyloid fragments of A40 and A42 may
be more easily exported from the neurons and vascu-
lature. Understanding the mechanism of age-related
changes in iA processing may finally lead to appli-
cation of countermeasures to prolong dementia-free
health span [19, 79].
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